04:14 AM EDT, 06/27/2025 (MT Newswires) -- (Updates with attribution to Eli Lilly ( LLY ) throughout.)

Eli Lilly ( LLY ) said Thursday that India's Central Drugs Standard Control Organization has granted marketing authorization for its Mounjaro obesity and type 2 diabetes drug in the KwikPen presentation.

All six dosage options for Mounjaro will be available in India soon, the drugmaker said.